FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

19496411000001107: Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Oct 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1748041000001110 Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1748051000001113 Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Is a Asenapine 10mg sublingual tablets sugar free 60 tablet true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has AMP Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has specific active ingredient Asenapine maleate true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has dispensed dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Asenapine true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Sycrest 10mg sublingual tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has basis of strength substance Asenapine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start